PaperPanda Equity Terminal

HALO logo HALO — Halozyme Therapeutics

CUSIP: 40637H109 · Held by 5 superinvestors · Combined value: $80,809,848

Latest News

Loading financials…

Quarterly Activity Chart Adds vs. Reduces by Quarter
Green bars = share additions · Red bars = share reductions
Superinvestor Holders
# Investor % of Portfolio Value ($) Shares Recent Activity Share Change
1 Jim Simons 0.1% $37,870,450 562,711 REDUCE -437,498
2 Ray Dalio 0.1% $37,794,132 561,577 ADD +74,496
3 Torray LLC 0.4% $2,467,509 38,179 ADD +44
4 Ken Griffin 0.0% $2,416,070 35,900 REDUCE -299,501
5 Richard Pzena 0.0% $261,687 4,049 REDUCE -229
Quarterly Activity History (3 quarters)
Investor Activity Share Change % Change
Torray LLC ADD +44 +0.1%
Richard Pzena REDUCE -229 -5.4%
Investor Activity Share Change % Change
Ray Dalio ADD +74,496 +15.3%
Richard Pzena ADD +171 +4.2%
Torray LLC ADD +14 -
Jim Simons REDUCE -437,498 -43.7%
Ken Griffin REDUCE -299,501 -89.3%
Investor Activity Share Change % Change
Ray Dalio NEW BUY +487,081 New
Jim Simons ADD +661,600 +195.4%
Ken Griffin REDUCE -77,197 -18.7%

Who Owns HALO? Superinvestor Holdings

Halozyme Therapeutics is held by 5 tracked superinvestors, with a combined position value of $81 million . The largest positions are held by Jim Simons (0.1% of portfolio), Ray Dalio (0.1% of portfolio), Torray LLC (0.4% of portfolio).

In the most recent quarter, 2 superinvestors added or initiated positions while 3 reduced or exited.